UBS Group AG

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$25,756,589	2,210,866	+1,550,980	+235%	$11.65	Q4 2025
30 Sep 2025	0%	-0%	$6,631,855	659,886	-207,049	-24%	$10.05	Q3 2025
30 Jun 2025	0%	+0%	$15,128,016	866,935	+275,753	+47%	$17.45	Q2 2025
31 Mar 2025	0%	-0%	$7,437,070	591,182	-421,519		$12.58	Q1 2025
31 Dec 2024	0%	+0%	$10,683,995	1,012,701	+902,819	+822%	$10.55	Q4 2024
30 Sep 2024	0%	+0%	$1,593,290	109,882	+44,960	+69%	$14.50	Q3 2024
30 Jun 2024	0%	-0%	$552,486	64,922	-39,519	-38%	$8.51	Q2 2024
31 Mar 2024	0%	+0%	$1,067,387	104,441	+102,713	+5944%	$10.22	Q1 2024
31 Dec 2023	0%	+0%	$9,469	1,728	+1,728	NEW	$5.48	Q4 2023
30 Jun 2023		-0%	$0	0	-2,903	-100%	$8.81	Q2 2023
31 Mar 2023	0%	+0%	$18,898	2,903	+2,903	NEW	$6.51	Q1 2023
30 Sep 2022		-0%	$0	0	-502	-100%	$8.81	Q3 2022
30 Jun 2022	0%	0%	$2,000	502	+163	+48%	$3.98	Q2 2022
31 Mar 2022		0%	$1,000	174	0		$5.75 ^*	Q1 2022
31 Mar 2022	0%	-0%	$1,000	339	-78,501	-100%	$2.95	Q1 2022
31 Dec 2021	0%	+0%	$525,000	78,840	+65,110	+474%	$6.66	Q4 2021
30 Sep 2021	0%	+0%	$137,000	13,730	+13,555	+7746%	$9.98	Q3 2021
30 Jun 2021	0%	-0%	$5,000	175	-3,364	-95%	$28.57	Q2 2021
31 Mar 2021	0%	+0%	$154,000	3,539	+3,446	+3705%	$43.52	Q1 2021
31 Dec 2020	0%	+0%	$4,000	93	+93	NEW	$43.01	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.